Brain metabolism in Alzheimer's disease: biological mechanisms of exercise

L Xu, R Liu, Y Qin, T Wang - Translational neurodegeneration, 2023 - Springer
Alzheimer's disease (AD) is a major subtype of neurodegenerative dementia caused by long-
term interactions and accumulation of multiple adverse factors, accompanied by …

Metabolic syndrome as a risk factor for Alzheimer's disease: a focus on insulin resistance

A Ezkurdia, MJ Ramírez, M Solas - International Journal of Molecular …, 2023 - mdpi.com
Alzheimer's disease (AD) is the main type of dementia and is a disease with a profound
socioeconomic burden due to the lack of effective treatment. In addition to genetics and …

Cerebral fructose metabolism as a potential mechanism driving Alzheimer's disease

RJ Johnson, F Gomez-Pinilla, M Nagel… - Frontiers in aging …, 2020 - frontiersin.org
The loss of cognitive function in Alzheimer's disease is pathologically linked with
neurofibrillary tangles, amyloid deposition, and loss of neuronal communication. Cerebral …

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

M Perluigi, F Di Domenico, E Barone… - Free Radical Biology and …, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly population
and has worldwide impact. The etiology of the disease is complex and results from the …

Intranasal administration of kyccsrk peptide rescues brain insulin signaling activation and reduces alzheimer's disease-like neuropathology in a mouse model for …

A Tramutola, S Lanzillotta, G Aceto, S Pagnotta… - Antioxidants, 2023 - mdpi.com
Down syndrome (DS) is the most frequent genetic cause of intellectual disability and is
strongly associated with Alzheimer's disease (AD). Brain insulin resistance greatly …

Sweet but bitter: Focus on fructose impact on brain function in rodent models

MS Spagnuolo, S Iossa, L Cigliano - Nutrients, 2020 - mdpi.com
Fructose consumption has drastically increased during the last decades due to the extensive
commercial use of high-fructose corn syrup as a sweetener for beverages, snacks and …

Hypoglycemic medicines in the treatment of Alzheimer's disease: Pathophysiological links between AD and glucose metabolism

Y Wang, H Hu, X Liu, X Guo - Frontiers in Pharmacology, 2023 - frontiersin.org
Alzheimer's Disease (AD) is a global chronic disease in adults with beta-amyloid (Aβ)
deposits and hyperphosphorylated tau protein as the pathologic characteristics. Although …

The positive side of the Alzheimer's disease amyloid cross-interactions: the case of the Aβ 1-42 peptide with tau, TTR, CysC, and ApoA1

L Ciccone, C Shi, D Di Lorenzo, AC Van Baelen… - Molecules, 2020 - mdpi.com
Alzheimer's disease (AD) represents a progressive amyloidogenic disorder whose
advancement is widely recognized to be connected to amyloid-β peptides and Tau …

Sleep–Wake Disorders in Alzheimer's Disease: A Review

YY Sun, Z Wang, HY Zhou… - ACS Chemical …, 2022 - ACS Publications
Alzheimer's disease (AD) is a multifactorial disease, and it has become a serious health
problem in the world. Senile plaques (SPs) and neurofibrillary tangles (NFTs) are two main …

Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome

C Lanzillotta, A Tramutola, G Di Giacomo… - Free Radical Biology …, 2021 - Elsevier
Dysregulation of brain insulin signaling with reduced downstream neuronal survival and
plasticity mechanisms are fundamental abnormalities observed in Alzheimer disease (AD) …